Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Taneja

Showing results (211-220 of 845) with videos related to

Pageof 85
Sort By:
The Journal of Urology|June 21, 2016
Re: Androgen Deprivation Therapy and Future Alzheimer's Disease RiskSamir S Taneja
The Journal of Urology|June 21, 2016
Re: Prostate Cancer Detection with Magnetic Resonance-Ultrasound Fusion Biopsy: The Role of Systematic and Targeted BiopsiesSamir S Taneja
The Journal of Urology|June 21, 2016
Re: Medium-Term Outcomes after Whole-Gland High-Intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry CohortSamir S Taneja
The Urologic Clinics of North America|May 3, 2016
HypogonadismSamir S Taneja
The Journal of Urology|June 12, 2012
Re: A comparative cost analysis of robot-assisted versus traditional laparoscopic partial nephrectomySamir S Taneja
The Journal of Urology|June 12, 2012
Re: Perioperative and renal function outcomes of minimally invasive partial nephrectomy for T(1b) and T(2a) kidney tumorsSamir S Taneja
The Journal of Urology|December 25, 2015
Re: Duration of Androgen Suppression before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910Samir S Taneja
The Journal of Urology|May 18, 2016
Re: Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and UrologistsSamir S Taneja
The Journal of Urology|May 19, 2016
Re: Nadir Testosterone within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Trial of Intermittent versus Continuous ADTSamir S Taneja
The Journal of Urology|February 19, 2016
Re: Prostate Biopsy Specimens with Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical OutcomesSamir S Taneja
Pageof 85

Showing results (211-220 of 845) with videos related to

Sort By:
Pageof 85
The Journal of Urology|June 21, 2016
Re: Androgen Deprivation Therapy and Future Alzheimer's Disease RiskSamir S Taneja
The Journal of Urology|June 21, 2016
Re: Prostate Cancer Detection with Magnetic Resonance-Ultrasound Fusion Biopsy: The Role of Systematic and Targeted BiopsiesSamir S Taneja
The Journal of Urology|June 21, 2016
Re: Medium-Term Outcomes after Whole-Gland High-Intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry CohortSamir S Taneja
The Urologic Clinics of North America|May 3, 2016
HypogonadismSamir S Taneja
The Journal of Urology|June 12, 2012
Re: A comparative cost analysis of robot-assisted versus traditional laparoscopic partial nephrectomySamir S Taneja
The Journal of Urology|June 12, 2012
Re: Perioperative and renal function outcomes of minimally invasive partial nephrectomy for T(1b) and T(2a) kidney tumorsSamir S Taneja
The Journal of Urology|December 25, 2015
Re: Duration of Androgen Suppression before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910Samir S Taneja
The Journal of Urology|May 18, 2016
Re: Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and UrologistsSamir S Taneja
The Journal of Urology|May 19, 2016
Re: Nadir Testosterone within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Trial of Intermittent versus Continuous ADTSamir S Taneja
The Journal of Urology|February 19, 2016
Re: Prostate Biopsy Specimens with Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical OutcomesSamir S Taneja
Pageof 85